Metabolism of vitamin D2 to 17,20,24-trihydroxyvitamin D2 by cytochrome P450scc (CYP11A1)

Drug Metabolism and Disposition

Volumn 37, Issue 4, 2009, Pages 761-767

  Nguyen, Minh N ^a   Slominski, Andrzej ^b   Li, Wei ^b   Ng, Yun Rui ^a   Tuckey, Robert C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17,20,24 TRIHYDROXYVITAMIN D2; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); DRUG METABOLITE; ERGOCALCIFEROL; ERGOCALCIFEROL DERIVATIVE; HYDROXYL GROUP; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHOLESTEROL METABOLISM; DRUG HYDROXYLATION; DRUG ISOLATION; DRUG METABOLISM; ENZYME ACTIVITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VITAMIN D METABOLISM;

25-HYDROXYVITAMIN D 2; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERGOCALCIFEROLS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 63849125216     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.025619     Document Type: Article

References (31)

1. Armas LA, Hollis BW, and Heaney RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89:5387-5391.
2. Bikle DD, Oda Y, and Xie Z (2004) Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol 89-90:355-360.
3. Brown AJ, Ritter CS, Holliday LS, Knutson JC, and Strugnell SA (2004) Tissue distribution and activity studies of 1,24-dihydroxyvitamin D2, a metabolite of vitamin D2 with low calcemic activity in vivo. Biochem Pharmacol 68:1289-1296.
4. Headlam MJ, Wilce MC, and Tuckey RC (2003) The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. BBA Biomembranes 1617:96-108.
5. 3-1α-hydroxylase) of bovine kidney mitochondria. Biochem Biophys Res Commun 105:320-327.
6. Holick MF (2003) Vitamin D: a millennium perspective. J Cell Biochem 88:296 -307.
7. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362-371.
8. 3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93:677-681.
9. HumeR, Kelly RW, Taylor PL, and Boyd GS (1984) The catalytic cycle ofcytochrome P-450scc and intermediates in the conversion of cholesterol to pregnenolone. Eur J Biochem 140:583-591.
10. Janjetovic Z, Zmijewski M, Tuckey RC, Nguyen MN, and Slominski A (2008) 20- Hydroxycholecalciferol and 20, 23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NFkB activity by increasing IkBα levels in normal and HaCaT-keratinocytes. J Invest Dermatol 128(S1):S20, 116.
11. Jefcoate CR, Simpson ER, Boyd GS, Brownie AC, and Orme-Johnson WH (1973) The detection of different states of the P-450 cytochromes in adrenal mitochondria; changes induced by ACTH. Ann N Y Acad Sci 212:243-261.
12. Kazanci N, Toyran N, Haris PI, and Severcan F (2001) Vitamin D2 at high and low concentrations exert opposing effects on molecular order and dynamics of dipalmitoyl phosphatidyl- choline membranes. Spectroscopy 15:47-55.
13. Lambeth JD, Kitchen SE, Farooqui AA, Tuckey R, and Kamin H (1982) Cytochrome P-450scc- substrate interactions. Studies of binding and catalytic activity using hydroxycholesterols. J Biol Chem 257:1876-1884.
14. 3-derivatives into liposomes of different lipid types. J Drug Target 2:411-417.
15. Meunier B, de Visser SP, and Shaik S (2004) Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chem Rev 104:3947-3980.
16. Mitani H, Naru E, Yamashita M, Arakane K, Suzuki T, and Imanari T (2004) Ergocalciferol promotes in vivo differentiation of keratinocytes and reduces photodamage caused by ultraviolet irradiation in hairless mice. Photodermatol Photoimmunol Photomed 20:215-223.
17. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
18. Prosser DE and Jones G (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29:664-673.
19. Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, and Tuckey RC (2006) An alternative pathway of vitamin D2 metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J 273:2891-2901.
20. Slominski A, Semak I, Zjawiony J, Wortsman J, Gandy MN, Li J, Zbytek B, Li W, and Tuckey RC (2005a) Enzymatic metabolism of ergosterol by cytochrome P450scc to biologically active 17a,24-dihydroxyergosterol. Chem Biol 12:931-939.
21. Slominski A, Semak I, Zjawiony J, Wortsman J, Li W, Szczesniewski A, and Tuckey RC (2005b) The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J 272:4080-4090.
22. Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, Sweatman T, Marcos J, Dunbar C, and Tuckey RC (2004) A novel pathway for sequential transformation of 7-dehy- drocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271:4178-4188.
23. Tuckey RC (2005) Progesterone synthesis by the human placenta. Placenta 26:273-281.
24. Tuckey RC and Cameron KJ (1993) Human placental cholesterol side-chain cleavage: enzymatic synthesis of (22R)-20 α, 22-dihydroxy cholesterol. Steroids 58:230-233.
25. Tuckey RC, Janjetovic Z, Li W, Nguyen MN, Zmijewski MA, Zjawiony JK, and Slominski A (2008c) Metabolism of 1 α-hydroxyvitamin D3 by cytochrome P450scc to biologically active lα,20-dihydroxyvitamin D3. / Steroid Biochem Mol Biol 112:213-219.
26. Tuckey RC, Li W, Zjawiony JK, Zmijewski MA, Nguyen MN, Sweatman T, Miller D, and Slominski A (2008a) Pathways and products for the metabolism of vitamin D3 by cytochrome k P450scc. FEBS J 275:2585-2596.
27. Tuckey RC, Nguyen MN, and Slominski A (2008b) Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. Int J Biochem Cell Biol 40:2619-2626.
28. scc incorporated into artificial phospholipid vesicles. Int J Biochem 16:497-503.
29. Tuckey RC and Stevenson PM (1984b) Properties of ferredoxin reductase and ferredoxin from the bovine corpus luteum. Int J Biochem 16:489-495.
30. scc incorporated into vesicles prepared from these phospholipids. Eur J Biochem 148:379-384.
31. sc, stimulates keratinocyte differentiation. J Invest Dermatol 128:22712280.